News & Perspective

(CIDRAP News) – Federal health officials are in the midst of crafting a framework for funding H5N1 avian influenza gain-of-function studies, and today at a workshop they heard varied feedback from researchers, biosecurity experts, and others.

(CIDRAP News) – A report released yesterday by the Government Accountability Office (GAO) offers yet another review of lessons from the federal government's response to the H1N1 influenza pandemic while detailing how the government spent, and is still spending, $6.15 billion that was appropriated for the response.

(CIDRAP News) – A workshop summary released today by the Institute of Medicine (IOM) offers a wide range of observations and suggestions about what worked well and not so well during the pandemic H1N1 influenza vaccination campaign—a complex, months-long operation with a cast of thousands.

(CIDRAP News) – A committee of experts appointed by the World Health Organization (WHO) convened today to begin evaluating the agency's and the world's response to the H1N1 influenza pandemic, with WHO Director-General Margaret Chan urging the group to pull no punches.

(CIDRAP News) – With the global outbreak of novel H1N1 influenza (swine flu) entering its fourth week, physicians at emergency rooms, clinics, and hospitals around the United States say they are overwhelmed with "worried well" who have as much as doubled their patient loads.

(CIDRAP News) – Toronto's city council yesterday approved a $1.5 million plan to treat nearly half of the municipal employee workforce with antiviral medication in the event of a pandemic scenario, making it the first major Canadian city to stockpile the drugs.

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.